Abbott Laboratories has announced it will stop introducing new drugs in Thailand because the government is breaking the patent on HIV med Kaletra, allowing cheaper generic versions to be purchased and produced locally. The Thai government has broken drug patents before, but Abbott is the first to retaliate.